CTN Dissemination Library

  • Browse & Search
    • Search the CTN Library
    • In press articles
    • Search the site/blog
  • Nodes
  • Protocols
  • Training
    • CTN & Other Training
    • Upcoming Events
  • Resources
    • What’s New Blog
    • NIDA CTN Site
    • CTN Bulletin
    • CTN Common Data Elements (CDE)
    • CTN Directory (2025)
    • PATHS Toolkit
    • Implementation
    • General Resources
  • About Us
  • Browse & Search
    • Search the CTN Library
    • In press articles
    • Search the site/blog
  • Nodes
  • Protocols
  • Training
    • CTN & Other Training
    • Upcoming Events
  • Resources
    • What’s New Blog
    • NIDA CTN Site
    • CTN Bulletin
    • CTN Common Data Elements (CDE)
    • CTN Directory (2025)
    • PATHS Toolkit
    • Implementation
    • General Resources
  • About Us
  • Does treatment readiness enhance the response of African American substance users to motivational enhancement therapy?

    Burlew AK, Montgomery L, Kosinski AS, Forcehimes AA. Does treatment readiness enhance the response of African American substance users to motivational enhancement therapy? Psychology of Addictive Behaviors 2013;27(3):744-753.

    Read More
  • A quasi-experimental study examining New York State’s tobacco-free regulation: Effects on clinical practice behaviors.

    de Tormes Eby LT, Laschober TC. A quasi-experimental study examining New York State's tobacco-free regulation: Effects on clinical practice behaviors. Drug and Alcohol Dependence 2013;132(1-2):158-164.

    Read More
  • Gender differences in a clinical trial for prescription opioid dependence.

    McHugh RK, DeVito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, Connery HS, Weiss RD. Gender differences in a clinical trial for prescription opioid dependence. Journal of Substance Abuse Treatment 2013;45(1):38-43.

    Read More
  • Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.

    Dreifuss JA, Griffin ML, Frost K, Fitzmaurice GM, Potter JS, Fiellin DA, Selzer JA, Hatch-Maillette MA, Sonne SC, Weiss RD. Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug and Alcohol Dependence 2013;131(1-2):112-118.

    Read More
  • Demographic and clinical characteristics of middle-aged versus younger adults enrolled in a clinical trial of a web-delivered psychosocial treatment for substance use disorders.

    Kalapatapu RK, Campbell ANC, Aharonovich E, Hu M, Levin FR, Nunes EV. Demographic and clinical characteristics of middle-aged versus younger adults enrolled in a clinical trial of a web-delivered psychosocial treatment for substance use disorders. Journal of Addiction Medicine 2013;7(1):66-72.

    Read More
  • Differences between men and women in condom use, attitudes, and skills in substance abuse treatment seekers.

    Calsyn DA, Peavy KM, Wells EA, Campbell ANC, Hatch-Maillette MA, Greenfield SF, Tross S. Differences between men and women in condom use, attitudes, and skills in substance abuse treatment seekers. American Journal on Addictions 2013;22:150-157.

    Read More
  • Gender differences in heterosexual anal sex practices among woman and men in substance abuse treatment.

    Calsyn DA, Hatch-Maillette MA, Meade CS, Tross S, Campbell ANC, Beadnell B. Gender differences in heterosexual anal sex practices among woman and men in substance abuse treatment. AIDS and Behavior 2013;17(7):2450-2458.

    Read More
  • Preventing addiction related suicide: A pilot study.

    Voss WD, Kaufman E, O'Connor SS, Comtois KA, Conner KR, Ries RK. Preventing addiction related suicide: A pilot study. Journal of Substance Abuse Treatment 2013;44(5):565-569.

    Read More
  • Treating nicotine dependence by targeting attention deficit/hyperactivity disorder (ADHD) with OROS methylphenidate: The role of baseline ADHD severity and treatment response.

    Nunes EV, Covey LS, Brigham GS, Hu M, Levin FR, Somoza EC, Winhusen TJ. Treating nicotine dependence by targeting attention deficit/hyperactivity disorder (ADHD) with OROS methylphenidate: The role of baseline ADHD severity and treatment response. Journal of Clinical Psychiatry 2013;74(10):983-990.

    Read More
  • Impulsivity is associated with treatment non-completion in cocaine- and methamphetamine-dependent patients but differs in nature as a function of stimulant-dependence diagnosis.

    Winhusen TJ, Lewis DF, Adinoff BH, Brigham GS, Kropp FB, Donovan DM, Seamans CL, Hodgkins CC, Botero CL, Jones DR, Somoza EC. Impulsivity is associated with treatment non-completion in cocaine- and methamphetamine-dependent patients but differs in nature as a function of stimulant-dependence diagnosis. Journal of Substance Abuse Treatment 2013;44(5):541-547.

    Read More
6364656667

Recent Posts

  • Now in the CTN Library: NIDA CTN Common Data Elements
  • New in the Library (March – April 2026)
  • CTN Primary Care SIG Webinar: Conducting Substance Use Research in Prison (March 23, 2026, 12pm ET)
  • New in the Library (February – March 2026)
  • News from the Appalachian Node: Brief Report for CTN-0135 Published

Recent Comments

No comments to show.

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • September 2022

Categories

  • DSC News
  • Events
  • Funding
  • Jobs
  • New in the Library
  • Node News
  • Other
  • Protocol News
  • SIG Updates
  • Uncategorized
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Department of Psychiatry & Behavioral Science's Addictions, Drug & Alcohol Institute (ADAI). The materials on this site have neither been created nor reviewed by NIDA.